Ugur Sahin, chief executive officer of BioNTech SE, sold 24,000 shares of $BNTX on October 7, 2026, at $95.8597 per share. The transaction totaled $2,300,632.80 and was reported as an open-market sale on a Form 4 filed the same day. After the sale, Sahin's reported holdings stood at 63,209 shares.
The October 7 filing followed two other disclosures in the same week. On October 6, Sahin sold 21,000 shares at $96.8093 per share for $2,032,995.30. On October 5, he sold 72,000 shares at $97.2312 per share for $7,000,646.40. Across those three trading days, the disclosed sales totaled 117,000 shares and $11,334,274.50.
The October sales extended a longer sequence of open-market sales by the same insider. From September 15 through October 7, Sahin reported 11 open-market sales of $BNTX totaling 365,000 shares for $35,618,722.10. The September portion included a 34,000-share sale on September 15 at $96.4893 per share, a 15,000-share sale on September 16 at $96.0893 per share, a 34,000-share sale on September 17 at $98.5983 per share, a 30,000-share sale on September 18 at $96.2243 per share, a 30,000-share sale on September 23 at $99.4027 per share, and a 39,000-share sale on September 24 at $98.9913 per share.
Later September disclosures included a 34,000-share sale on September 29 at $98.2591 per share and a 32,000-share sale on September 30 at $98.1203 per share.
Reported holdings moved lower across the filings. Sahin reported 568,209 shares owned after the September 15 sale, 341,209 after the September 24 sale, 108,209 after the October 5 sale, and 63,209 after the October 7 sale.
Several of the filings arrived shortly after the trade dates. The September 15 sale was filed on September 16, the September 17 and September 18 sales were filed on September 18, the September 23 and September 24 sales were filed on September 24, and the September 29 and September 30 sales were filed on September 30. The October 5 and October 6 sales were filed on October 6, while the October 7 sale was filed on the trade date.
The congressional STOCK Act table showed no $BNTX disclosures dated in 2026. The most recent congressional transaction for the ticker in the database was a sale by Rep. Valerie Hoyle, dated August 7, 2025 and disclosed September 12, 2025. Earlier $BNTX disclosures included multiple transactions by Rep. Josh Gottheimer between December 2023 and September 2024.
Daily price data for $BNTX showed an October 5 close of $97.64. Sahin's October 5 sale was reported at $97.2312 per share. The Form 4 disclosures report changes in beneficial ownership by corporate insiders.